GIUGGIOLI, DILIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.626
EU - Europa 12.109
AS - Asia 2.655
SA - Sud America 39
AF - Africa 27
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 15
Totale 31.490
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.531
IT - Italia 4.728
GB - Regno Unito 3.828
SE - Svezia 1.063
CN - Cina 879
DE - Germania 677
SG - Singapore 556
UA - Ucraina 525
TR - Turchia 454
HK - Hong Kong 420
FR - Francia 377
FI - Finlandia 357
BG - Bulgaria 220
ID - Indonesia 94
CA - Canada 60
IE - Irlanda 58
IN - India 58
RU - Federazione Russa 53
BE - Belgio 38
JP - Giappone 38
LT - Lituania 34
KR - Corea 31
VN - Vietnam 31
IR - Iran 28
MY - Malesia 28
BZ - Belize 26
NL - Olanda 22
RO - Romania 20
CZ - Repubblica Ceca 19
CH - Svizzera 18
AU - Australia 15
ES - Italia 15
EU - Europa 13
ZA - Sudafrica 12
PL - Polonia 11
AR - Argentina 10
BR - Brasile 9
HU - Ungheria 8
TW - Taiwan 8
CL - Cile 7
EG - Egitto 7
IL - Israele 7
MX - Messico 7
PK - Pakistan 7
PT - Portogallo 6
CO - Colombia 5
TH - Thailandia 5
BY - Bielorussia 4
LU - Lussemburgo 4
NZ - Nuova Zelanda 4
RS - Serbia 4
AT - Austria 3
GR - Grecia 3
PE - Perù 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AL - Albania 2
IQ - Iraq 2
MA - Marocco 2
MD - Moldavia 2
MK - Macedonia 2
NO - Norvegia 2
SI - Slovenia 2
TN - Tunisia 2
VE - Venezuela 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
CM - Camerun 1
CR - Costa Rica 1
DZ - Algeria 1
EC - Ecuador 1
ET - Etiopia 1
HR - Croazia 1
IM - Isola di Man 1
JO - Giordania 1
KZ - Kazakistan 1
NG - Nigeria 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
VA - Santa Sede (Città del Vaticano) 1
Totale 31.490
Salva come PNG Salva come JPEG
Città #
Southend 3.361
Fairfield 2.598
Woodbridge 1.480
Chandler 1.325
Ashburn 1.258
Houston 1.170
Jacksonville 940
Seattle 917
Wilmington 844
Cambridge 828
Ann Arbor 740
Nyköping 679
Dearborn 621
Hong Kong 417
Singapore 361
Milan 344
Modena 307
Izmir 294
San Diego 284
Rome 283
Beijing 243
Princeton 234
Helsinki 217
Sofia 217
New York 170
Eugene 157
Bologna 121
Bremen 120
Redwood City 104
London 96
Jakarta 92
Des Moines 90
Florence 88
Los Angeles 78
Palermo 75
Shanghai 74
Naples 70
Atlanta 65
Falls Church 59
Frankfurt am Main 57
Catania 51
Norwalk 50
San Jose 48
Bari 47
Turin 44
Boardman 43
Dublin 43
Padova 40
Genoa 35
Guangzhou 34
Verona 34
Brussels 32
Cagliari 29
Belize City 26
Dong Ket 26
Brescia 25
Hounslow 24
Parma 24
Nanjing 23
Reggio Emilia 23
Toronto 22
Kunming 21
Chicago 20
Hefei 20
Salerno 20
Treviso 20
Ottawa 19
Phoenix 18
San Mateo 18
Indiana 17
Kilburn 17
Tokyo 17
Brno 16
Chiswick 16
Bergamo 15
Dallas 15
Munich 15
Napoli 15
Philadelphia 15
Pisa 15
Grafing 14
Leawood 14
Legnano 14
Messina 14
Jinan 13
Mountain View 12
Novara 12
Perugia 12
Saint Louis 12
Trento 12
Venice 12
Livorno 11
Pescara 11
Antalya 10
Forlì 10
Islington 10
Johannesburg 10
Paris 10
San Francisco 10
Trieste 10
Totale 22.763
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.051
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 694
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 674
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 619
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 282
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 271
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series 238
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 236
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 235
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 234
Current treatment of hepatitis C-associated rheumatic diseases. 225
Elevated Troponin Serum Levels in Adult Onset Still's Disease 222
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 222
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 221
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 209
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 209
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 202
Aortic pulse wave velocity measurement in systemic sclerosis patients. 200
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 198
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 195
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 195
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 192
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 191
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 190
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 189
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 189
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 186
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 186
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 185
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 182
Correlation of articular involvement, skin disfigurement, and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample 181
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 181
HCV-related rheumatic manifestations and therapeutic strategies 180
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 180
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 180
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 179
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature. 179
Associations between Systemic Sclerosis and Thyroid Diseases 178
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 177
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 175
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 175
SAT0633-HPR Articular Involvement of the Scleroderma Hand: An Assessment Protocol for Planning Occupational Therapy Strategies 173
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis. 173
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 171
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 171
Renal Manifestations of Hepatitis C Virus 166
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients 165
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 164
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 163
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 160
Heart involvement and systemic sclerosis 159
Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis 159
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 159
Scleroderma digital ulcers complicated by infection with fecal pathogens. 159
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 159
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 159
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 158
Phantom Limb Pain in Patients with Severe Cryoglobulinemic Vasculitis: Usefulness of Long-Term Pregabalin Treatment 157
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 157
Treatment of HCV-related mixed cryoglobulinemia 157
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 157
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 156
The safety of iloprost in systemic sclerosis in a real-life experience 154
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer 154
Amlodipine in the treatment of Raynaud's phenomenon 153
Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection 153
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 153
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report 151
Novel Therapies for Thyroid Autoimmune Diseases 151
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 151
Systemic sclerosis following human cytomegalovirus infection 150
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 150
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 150
Severe alopecia complicating systemic sclerosis 149
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 149
Procedural pain management in the treatment of scleroderma digital ulcers 148
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia 148
The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients 147
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 147
L-Arginine in pregnant scleroderma patients 147
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 145
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 145
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 144
Osteomyelitis complicating scleroderma digital ulcers. 142
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 142
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 142
Platelet gel in the treatment of severe scleroderma skin ulcers. 140
Right ventricular overload and cardiovascular neuroendocrine derangement in systemic sclerosis 137
Cardiovascular risk and prostanoids in systemic sclerosis 137
COVID-19 in Italian patients with rheumatic autoimmune systemic diseases 137
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 135
Trattamento con IgIV ad alte dosi in un caso di dermatomiosite con grave disfagia refrattaria alle terapie standard. 133
Thyroid involvement in patients with HCV-related mixed cryoglobulinaemia 133
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures 132
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 132
Reactive arthritis induced by intravesical BCG therapy for bladder cancer: our clinical experience and systematic review of the literature 132
Human Parvovirus B19 (B19V) Infection in Systemic Sclerosis Patients 131
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 131
HCV associated cryoglobulinemic vasculitis 130
Thymus alterations and systemic sclerosis 130
Totale 21.324
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.996
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.772 0 0 0 306 526 1.005 826 775 570 214 333 217
2020/20215.943 384 213 333 460 579 492 1.048 796 315 526 494 303
2021/20224.403 221 363 353 386 166 334 194 269 463 381 741 532
2022/20235.029 579 419 282 369 592 677 260 478 651 153 324 245
2023/20244.331 184 282 254 492 753 327 363 472 109 237 349 509
2024/20251.075 468 213 240 154 0 0 0 0 0 0 0 0
Totale 31.996